| Application no. and date | 15720314.2 (espacenet) (Federated) (European Patent Register), 20150427 | | Patent/reg. no. and date | DK/EP 3134125, 20191009 | | Publication date | 20170301 | | Priority no. and date | EP 14305621, 20140425 | | EP pub. no. and date |
EP 3134125 20170301 | | Effective date | | | Applicant/owner | Pierre Fabre Médicament, 45, Place Abel Gance
92100 Boulogne-Billancourt, FR | | Applicant ref. no. | P81905217DK00E | | Inventor | PEREZ, Michel, 45 chemin de la Pique
81100 Castres, FR,
HAEUW, Jean-François, 30 Domaine du Salève
Route du Salève
74160 Beaumont, FR,
GOETSCH, Liliane, 15 Route de Cluze
74130 Ayze, FR,
BROUSSAS, Matthieu, 13b Rue du Lieutenant Bovagne
Immeuble les Terrasses
01420 Seyssel, FR,
RILATT, Ian, 67 Chemin de Montplaisir
81100 Castres, FR,
BEAU-LARVOR, Charlotte, 156 Rue du Champs à la Moine
Hameau de Vigny
74520 Jonzier Epagny, FR,
LAMOTHE, Marie, 2 Route des Mines
81360 Montredon Labessonnie, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/50 (2017.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) | | Title | Antistof-lægemiddel-konjugat og anvendelse deraf til behandling af cancer | | Int. application no. | EP2015059052 | | Int. publication no. | WO2015162293 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
